Cholesterol and diabetes drugs were found to lower the prevalence of any type of age-related macular degeneration by 15% and 22%, respectively.
A dietary supplement formula is effective at slowing the progression of age-related macular degeneration, finds new research funded by the National Institutes of Health.
Unaddressed vision problems may skew the results of cognitive tests and lead to inaccurate diagnoses of mild cognitive impairment, researchers say.
Faricimab noninferior to aflibercept for visual acuity gains in neovascular age-related macular degeneration, diabetic macular edema
FDA approves eye drug Vabysmo to treat ‘wet’ macular degeneration in older adults … Diet rich in flavonoid-rich foods boosts longevity in Parkinson’s disease … Allopurinol not linked to higher...
The FDA has approved an ocular implant that could reduce the treatment schedule from monthly to twice yearly for older adults with “wet” macular degeneration.
Biosimilar to Lucentis approved to treat neovascular age-related macular degeneration, macular edema, myopic choroidal neovascularization
The Food and Drug Administration has approved a less expensive copy of the blockbuster drug Lucentis for treating age-related (wet) macular degeneration and several other eye conditions.
Risk increased in association with age-related macular degeneration, cataract, diabetes-related eye disease, but not glaucoma
Use of opioids a balancing act when treating pain in residents with Alzheimer’s … GSK halts nationwide production of 2 Excedrin drugs … Drug combo reverses arthritis in rats … Discovery may lead...
Please login or register first to view this content.